CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
4.18
1.18%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.13
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026262 %
Charges from full value of position ($-4.99)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026262%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00404 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00404%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 4.23
Open 4.19
1-Year Change -11.42%
Day's Range 4.18 - 4.19
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 15, 2024 4.23 0.05 1.20% 4.18 4.23 4.14
Jul 12, 2024 4.24 0.06 1.44% 4.18 4.24 4.12
Jul 11, 2024 4.18 0.00 0.00% 4.18 4.26 4.13
Jul 10, 2024 4.18 0.04 0.97% 4.14 4.22 4.10
Jul 9, 2024 4.14 0.00 0.00% 4.14 4.16 4.14
Jul 8, 2024 4.15 0.01 0.24% 4.14 4.19 4.08
Jul 5, 2024 4.19 0.00 0.00% 4.19 4.19 4.17
Jul 3, 2024 4.14 -0.01 -0.24% 4.15 4.24 4.14
Jul 2, 2024 4.09 -0.37 -8.30% 4.46 4.46 4.09
Jul 1, 2024 4.38 -0.15 -3.31% 4.53 4.54 4.34
Jun 28, 2024 4.69 0.40 9.32% 4.29 4.72 4.23
Jun 27, 2024 4.22 -0.10 -2.31% 4.32 4.51 4.21
Jun 26, 2024 4.34 0.09 2.12% 4.25 4.47 4.13
Jun 25, 2024 4.49 0.16 3.70% 4.33 4.50 4.29
Jun 24, 2024 4.36 0.01 0.23% 4.35 4.48 4.22
Jun 21, 2024 4.47 0.22 5.18% 4.25 4.47 4.17
Jun 20, 2024 4.27 0.18 4.40% 4.09 4.30 4.09
Jun 18, 2024 4.19 -0.10 -2.33% 4.29 4.33 4.08
Jun 17, 2024 4.27 0.13 3.14% 4.14 4.30 3.98
Jun 14, 2024 4.17 0.08 1.96% 4.09 4.18 4.09

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

ImmuCell Company profile

About ImmuCell Corporation

ImmuCell Corporation is an animal health company. The Company is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. It expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The Company is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.

Financial summary

BRIEF: For the nine months ended 30 September 2021, ImmuCell Corporation revenues increased 19% to $13.8M. Net loss decreased 87% to $152K. Revenues reflect First Defense® product line segment increase of 44% to $9.5M, Other animal health segment increase of 83% to $186K, United States segment increase of 18% to $12.2M, Others segment increase of 28% to $1.6M.

Equity composition

Common Stock $.10 Par, 12/10, 8M auth., 3,261,148 issd., less 287,496 shs. in Treas. @ $635K. Insiders own 26.70%. PO 5/87, 966,000 Units (100 Common + 5 Warrants) @ $7/Unit by Stuart James. 7/90, 1-for-100 reverse stock split.

Industry: Biotechnology & Medical Research (NEC)

56 Evergreen Drive
PORTLAND
MAINE 04103
US

People also watch

Gold

2,447.13 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.31

US100

20,344.50 Price
-0.350% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

0.58 Price
+7.760% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,407.97 Price
-0.910% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading